Supplementation with omega-3 significantly improves certain symptoms related to endometrial hyperplasia (EH), but not its inflammatory and oxidative stress biomarkers, Iranian researchers have found.
A recent panel discussion hosted by NutraIngredients-USA pointed out that the omega-3s market is robust, albeit slowly growing, but also that it could be so much more.
Humans consuming omega-3 supplements can convert EPA (eicosapentaenoic acid) to DHA (docosahexaenoic acid), but this is only a one-way street, and no retroconversion occurs, says a new study that extends our knowledge of how we respond to supplementation.
International marine certifiers Friend of the Sea (FOS) has certified German-based LR Health & Beauty for its efforts to promote sustainability of its omega-3 enriched-products.
Aker BioMarine believes that gaining the ‘blue-hat’ certification will boost krill oil awareness in the Chinese market and has revealed it is expecting its application results soon.
Despite ongoing concerns among environmentalists about the health of the world’s oceans, data supports a positive outlook for the continued sustainability of the supply of marine ingredients.
Swisse and Biolsland took the top spots for imported brands in China last year, with Australia named the number one exporter to China, according to statistics gathered by the China Chamber of Commerce of Medicines and Health Products Importers and Exporters...
The recent success of an omega 3 drug trial should help to reinvigorate research into these ingredients’ effects, especially at higher dosages, said one of the field’s prominent experts.
Japanese researchers have found that Cognizin Citicoline in combination with DHA, can improve learning and memory ability in mice which have been subjected to stroke symptoms.
Having a plethora of processing capabilities will help omega-3s companies hold their own in an increasingly competitive market that is showing signs of maturity, a prominent executive says.
Global omega-3 player KD Pharma says the new site at Seal Sands will expand its capacity for manufacturing omega-3-based intermediates, especially for those use in producing active pharmaceutical ingredients (APIs).
Increased levels of omega-3s may be associated with less aortic calcification among men in the general population, with the effects seemingly driven by DHA (docosahexaenoic acid), says a new study.
The infant nutrition market is characterized by few new ingredients, but lots of new players, according to information shared at a recent event hosted by ingredient supplier DSM.
